首页> 外国专利> It is composed of morphine pyridine derivatives, pharmacological components and m-tor-qunasa inhibitors for the treatment of L to inflammation, cancer, immune disease, pulmonary obstructive disease and cardiovascular disease.

It is composed of morphine pyridine derivatives, pharmacological components and m-tor-qunasa inhibitors for the treatment of L to inflammation, cancer, immune disease, pulmonary obstructive disease and cardiovascular disease.

机译:它由吗啡吡啶衍生物,药理成分和间-古拉素抑制剂组成,用于治疗L引起的炎症,癌症,免疫疾病,肺阻塞性疾病和心血管疾病。

摘要

Pyrimidine derivatives (Compounds, Pharmaceutical Composition and its use in cancer, inflammation, immune diseases, Obstructive Lung Disease, cardiovascular disease, among others.Through the Modulation of the M - Tor Kinase.
机译:嘧啶衍生物(化合物,药物组合物及其在癌症,炎症,免疫疾病,阻塞性肺疾病,心血管疾病等中的用途)通过M-Tor激酶的调节。

著录项

  • 公开/公告号CL2008002006A1

    专利类型

  • 公开/公告日2009-06-26

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CL20080002006

  • 发明设计人 MORRIS JEFFREY JAMES PIKE KURT GORDON;

    申请日2008-07-09

  • 分类号A61K31/5377;A61P29/00;A61P35/00;A61P37/02;A61P9/00;C07D239/42;C07D265/30;C07D285/08;C07D417/14;

  • 国家 CL

  • 入库时间 2022-08-21 19:28:19

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号